GENE ONLINE|News &
Opinion
Blog

Esophageal Squamous Cell Carcinoma
Innovent, Lilly’s PD-1 Inhibitor Approved to Treat Esophageal Cancer in China
2022-06-21
Lilly, Innovent’s Tyvyt Registers Positive Outcomes in Esophageal and Gastric Cancer Trials
2021-09-17
FDA Accepts BeiGene’s BLA for Esophageal Cancer Drug
2021-09-14
BeiGene’s Immunotherapy Drug Shines in Phase ESCC Trial
2021-01-31
Keytruda Receives Two New Approvals in Japan
2020-08-30
LATEST
GSK Bets $593 Million To License Scynexis’ Oral Antifungal
2023-03-31
3D Printed Brain Model Could Aid in Neurosurgery
2023-03-31
Latest Study on Neuronal Gene Expression May Shed Light on the Memory Formation Process
2023-03-30
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Current Trends of iPSC Manufacturing and Clinical Applications – An Interview with Professor Xianmin Zeng
2023-03-29
U.S.-German Joint Discovery May Spark Breakthrough in Diabetes Research
2023-03-29
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Scroll to Top